Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Implants and Prosthetics

Breast Implants Inicio
          Medical Devices
          Products and Medical Procedures
          Implants and Prosthetics
          Breast ImplantsImplants and Prosthetics Breast Implants
  	
        Share
    Post
    Linkedin

    Email
    PrintFDA Strengthens Breast Implant Safety Requirements

On October 27, 2021, the FDA took several actions to strengthen breast implant risk communication and help those who are considering breast implants make informed decisions.   These actions include orders restricting the sale and distribution of breast implants to help ensure that patients considering breast implants are provided with adequate risk information so that they can make fully informed decisions. These FDA requirements are described in detail at FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants.  In addition, the FDA regularly updates information on the status of breast implant manufacturers’ post-approval studies, at Post-Approval Studies (PAS) Database.

Hands holding a pair of breast implants.Breast implants are medical devices implanted under the breast tissue or chest muscle to increase breast size (augmentation) or to replace breast tissue that has been removed due to cancer or trauma or that has failed to develop properly due to a severe breast abnormality (reconstruction). They are also used in revision surgeries, which seek to correct or improve the result of an original surgery.

There are two types of breast implants approved for sale in the United States: saline-filled and silicone gel-filled. Both types have a silicone outer shell. They vary in size, shell thickness, shell surface texture, and shape (contour).

The information provided on this website is designed to support, not replace, the discussion that exists between a patient and a physician. We have provided this information to help women make informed decisions about whether or not to get breast implants:

Explain the risks of breast implants and describe the surgical procedures used to implant them.
	Provide information on saline-filled and silicone gel-filled breast implants, including data supporting a reasonable assurance of safety and effectiveness, approval letters, labeling and information on post-approval studies.
	Provide information on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in women with breast implants.
	Encourage patients to report adverse events associated with breast implants through the FDA's MedwatchFDA Guidances on Breast Implants

**Breast Implants - Certain Labeling Recommendations to Improve Patient Communication (2020)**: Provides recommendations concerning the content and format for certain labeling information for saline and silicone gel-filled breast implants, including:

	Boxed warning (page 4 of the guidance)
		Patient decision checklist (page 5 of the guidance)
		Materials/device descriptions, including types and quantities of chemicals and heavy metals found in or released by breast implants
		Silicone gel-filled breast implant rupture screening recommendations
		Patient device card
		The recommendations in this guidance supplement the recommendations in the FDA's Saline, Silicone Gel, and Alternative Breast Implants guidance, issued September 29, 2020, superseding the prior version dated November 17, 2006.

		
		The new labeling approved on October 27, 2021 follows from the labeling recommendations described in the FDA's September 2020 guidance.

		

		If you wish to submit an electronic comment on the final guidance, you may visit the docket page on Regulations.gov. Of the three tabs under the title, select "Browse Documents." Click on the title of the fourth document listed (labeled "OTHER"), "Breast Implants - Certain Labeling Recommendations to Improve Patient Communication Guidance for Industry and Food and Drug Administration Staff." IMPORTANT: make sure the posted date is listed as "Sep 29, 2020" because there may be more than one document with this title listed there. Enter your comments by clicking on the blue "Comment" button under the title.
	**Saline, Silicone Gel, and Alternative Breast Implants (2006)**Restrictions on Sale and Distribution of Breast Implants

The restrictions on sale and distribution are included in the Post-Market Approval (PMA) Supplement Approval letter for these implants.

Allergan Natrelle Silicone Gel-Filled Breast Implants
	IDEAL Implant Structured Breast Implants
	Mentor MemoryShape Silicone-Filled Breast Implants
	Mentor MemoryGel Silicone-Filled Breast Implants
	Mentor Saline-Filled and Spectrum Breast Implants
	Allergan Natrelle Saline Filled Breast Implants
	Sientra OPUS Silicone Gel Breast ImplantsSafety Communications on Breast Implants

UPDATE: Reports of Squamous Cell Carcinoma (SCC) in the Capsule Around Breast Implants - FDA Safety Communication (3/8/2023)
	Breast Implants: Reports of Squamous Cell Carcinoma and Various Lymphomas in Capsule Around Implants: FDA Safety Communication (9/8/2022)
	Acellular Dermal Matrix (ADM) Products Used in Implant-Based Breast Reconstruction Differ in Complication Rates: FDA Safety Communication (3/31/2021)
	The FDA Requests Allergan Voluntarily Recall Natrelle BIOCELL Textured Breast Implants and Tissue Expanders from the Market to Protect Patients: FDA Safety Communication (7/24/2019)Press Releases and Statements on Breast Implants

CDRH Statement: CDRH Updates Safety Communication for Squamous Cell Carcinoma (SCC) in Scar Tissue around Breast Implants (3/8/2023)
	FDA Statement: FDA Issues Safety Alert for Squamous Cell Carcinoma and Various Lymphomas in Scar Tissue around Breast Implants(9/8/2022)
	FDA News Release: FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants (10/27/2021)
	FDA News Release: FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma (8/20/2020)
	FDA News Release: FDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patients (5/14/2020)
	FDA News Release: FDA takes action to protect patients from risk of certain textured breast implants; requests Allergan voluntarily recall certain breast implants and tissue expanders from market: (7/24/2019)
	Statement from FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., and Jeff Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health on FDA's new efforts to protect women's health and help to ensure the safety of breast implantsReports on Silicone Gel-Filled Breast Implants

Update on the Safety of Silicone Gel-Filled Breast Implants (2011) (PDF - 1.5MB)
	Update on the Safety of Silicone Gel-Filled Breast Implants (2011) - Executive SummaryOther Resources

Consumer Update: What to Know About Breast Implants
	2021 Meeting Materials of the General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee Announcement
	2019 Meeting Materials of the General and Plastic Surgery Devices Panel: Breast Implant Special Topics
	Report a Problem with Breast Implants

                                                                                  Content current as of:
      12/15/2023
                  
                   
Regulated Product(s)
		 Medical DevicesBreast Implants
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop